Article Text

Download PDFPDF

Does the index-to-ring finger length ratio (2D:4D) differ in amyotrophic lateral sclerosis (ALS)? Results from an international online case–control study
  1. Jane Alana Parkin Kullmann,
  2. Roger Pamphlett
  1. Discipline of Pathology, Sydney Medical School, Brain and Mind Centre, The University of Sydney, Sydney, Australia
  1. Correspondence to Professor Roger Pamphlett; roger.pamphlett{at}sydney.edu.au

Abstract

Objectives The ratio of the length of the index finger (2D) to the ring finger (4D) (2D:4D) has been reported to be lower (ie, 2D<4D) in people with amyotrophic lateral sclerosis (ALS) than non-ALS controls. This has led to suggestions that exposure to increased prenatal testosterone, which also lowers this ratio, could be a risk factor for ALS. In an attempt to test this hypothesis, we examined 2D:4Ds from large numbers of patients with ALS and controls.

Setting An online multilingual questionnaire enabling respondents to measure their own index and ring finger lengths.

Participants Of the initial 949 respondents, 572 remained for analysis after elimination for inability to straighten fingers, not answering the question, statistical outliers and aged <40 years. Respondents remaining for analysis were 202 patients with ALS (125 males, 77 females) and 370 non-ALS controls (112 males, 258 females).

Results Unpaired t-tests with 95% CIs were used to assess differences in mean 2D:4Ds. Males had significantly lower mean 2D:4Ds than females, in both ALS and control groups, for both left and right hands. No significant differences were found in 2D:4Ds between ALS and control groups, in either males or females, for either left or right hands. Receiver operating characteristic curves showed no power for 2D:4Ds to predict ALS status in either males or females.

Conclusions 2D:4Ds did not differ between patients with ALS and controls in this study. This was despite the dataset being large enough to confirm the established finding of lower 2D:4Ds in males compared with females. These findings do not support the hypothesis that exposure to increased prenatal testosterone is a risk factor for ALS. A putative lower 2D:4D has been proposed to explain the link between ALS and exercise, but our results indicate that other exercise-related factors are more likely to explain this association.

  • amyotrophic lateral sclerosis
  • ALS
  • motor neuron disease
  • 2D:4D
  • finger lengths
  • digit lengths
  • web-based questionnaire
  • international survey
  • online study
  • case-control study
  • prenatal testosterone
  • exercise
  • physical activity

This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors JAPK and RP planned the project, acquired and analysed the data, wrote the manuscript (JAPK wrote the first draft), approved the final version submitted and are accountable for all aspects of the work.

  • Funding Supported by the Aimee Stacy Memorial and Ignacy Burnett Motor Neuron Disease bequests.

  • Competing interests The study was partially funded by the Aimee Stacy Memorial Bequest and the Ignacy Burnett Motor Neuron Disease Bequest, both managed by the University of Sydney.

  • Patient consent Participants consented to answering the online questionnaire by following these instructions: “Please click on the I Consent button below to indicate your consent to enter data into the questionnaire. By clicking this button, I: 1. Acknowledge that I have read the Information for Participants above and agree to participate in this research. 2. Understand that I will not be asked for any personal information that could identify me, so the study is anonymous and strictly confidential. 3. Freely choose to participate in the study and understand that I can withdraw my questionnaire answers at any time until I click the Submit button at the end of the questionnaire.”

  • Ethics approval The Human Ethics Committee of the Sydney Local Health District.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data sharing statement No additional unpublished data from the study (apart from the two supplementary files) are available.